Increased resistance of crosslinked cornea against enzymatic digestion
Top Cited Papers
- 1 January 2004
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 29 (1) , 35-40
- https://doi.org/10.1080/02713680490513182
Abstract
Purpose. Collagen-crosslinking using combined riboflavin/UVA treatment has been developed by us as a new treatment for keratoconus by stiffening the collagenous matrix. Recently, we have started to use the same method for the treatment of corneal ulcers. The aim of the present study was to evaluate the influence of the crosslinking treatment on the resistance of the cornea against enzymatic degradation. Methods. 60 enucleated porcine eyes were treated with the photosensitizer riboflavin and UVA-irradiation (370 nm; irradiance of 1, 2 or 3 mW/cm2) for 30 minutes and compared with 20 untreated control eyes. After crosslinking treatment, the corneal buttons were trephined and exposed to pepsin, trypsin and collagenase solutions. The extent of the corneal digestion was monitored daily. Selected cases were examined by light microscopy. Results. The corneal buttons crosslinked with riboflavin/UVA at 3 mW/cm2 were dissolved only by day 13 following pepsin digestion and by day 14 following collagenase treatment versus 6 days in the untreated control corneas. Digestion by trypsin was observed on day 5 in buttons crosslinked at 3 mW/cm2 compared to day 2 in the control corneas. Microscopically, a prolonged preservation especially of the anterior portion of the crosslinked corneas could be demonstrated. Conclusions. Photochemical crosslinking of the cornea using riboflavin and UVA results in a markedly increased resistance versus collagen digesting enzymes. The findings support the use of the new method in the treatment of corneal ulcers.Keywords
This publication has 9 references indexed in Scilit:
- Endothelial cell damage after riboflavin–ultraviolet-A treatment in the rabbitJournal of Cataract & Refractive Surgery, 2003
- Bestrahlung der Hornhaut mit UV-Licht und Riboflavingabe als neuer Behandlungsversuch bei einschmelzenden Hornhautprozessen, erste Ergebnisse bei vier Patienten123Klinische Monatsblätter für Augenheilkunde, 2000
- Levels of Collagen Degradation Products (Telopeptides) in the Tear Film of Patients with KeratoconusCornea, 2000
- Cross-linking of amniotic membranesJournal of Biomaterials Science, Polymer Edition, 1999
- Crosslinking density and resorption of dimethyl suberimidate-treated collagenJournal of Biomedical Materials Research, 1997
- Effect of physical crosslinking methods on collagen-fiber durability in proteolytic solutionsJournal of Biomedical Materials Research, 1996
- Autoimmunerkrankungen der peripheren Hornhaut - Immunpathologie, Klinik und TherapieKlinische Monatsblätter für Augenheilkunde, 1996
- The Cross-Linking and Structure Modification of the Collagen Matrix in the Design of Cardiovascular ProsthesisJournal of Cardiac Surgery, 1988
- Collagenase Inhibitors: Rationale for Their Use in Treating Corneal UlcerationInternational Ophthalmology Clinics, 1975